Fundz

STERIS to acquire Xodus Medical for $2.1B

PUBLIC · STEOct 12, 2026

Acquiring Company

STERIS plc

Acquired Company

Xodus Medical

MentorBiotechnologyHealth CareBiotechnologyHealth CareMedicalMedical Device

Description

STERIS STE has agreed to acquire Xodus Medical for $2.1 billion. The deal is expected to close by December 31, 2026, subject to regulatory approvals. Xodus Medical will generate approximately $245 million in revenue by 2026. The acquisition will contribute to tax benefits with a net present value of about $300 million.

Quick answer

STERIS plc is acquiring Xodus Medical for $2.1 billion, announced October 12, 2026. STERIS plc is based in Mentor, Ohio, United States.

How much did STERIS plc pay for Xodus Medical?
The reported deal value is $2.1 billion.
What does STERIS plc do?
STERIS plc is a global leader in providing infection prevention and other procedural products and services.
Where are STERIS plc and Xodus Medical based?
STERIS plc is based in Mentor, Ohio, United States.
Who are the decision-makers at STERIS plc?
Fundz holds 3 contacts at STERIS plc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at STERIS plc, and when

When STERIS plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day STERIS plc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at STERIS plc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at STERIS plc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

STERIS plc

Location

5960 Heisley Road

Mentor, Ohio, United States

About

STERIS plc is a global leader in providing infection prevention and other procedural products and services. The company focuses on improving patient outcomes and healthcare efficiency. With its wide range of innovative solutions, STERIS serves various markets, including healthcare and pharmaceutical industries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment STERIS plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tara
Senior decision-maker at this company
••••••••@••••••••

See Tara's verified email →

Brian
Senior decision-maker at this company
••••••••@••••••••

See Brian's verified email →

Marjorie
Senior decision-maker at this company
••••••••@••••••••

See Marjorie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for STERIS plc's next move

Learn about Strategic plan

Frequently asked

Who acquired Xodus Medical?

Xodus Medical was acquired by STERIS plc, based in Mentor. The deal was reported on October 12, 2026. STERIS plc is a global leader in providing infection prevention and other procedural products and services. The company focuses on improving patient outcomes and healthcare efficiency. STERIS plc is publicly traded (STE) and operates in Biotechnology.

When did STERIS plc acquire Xodus Medical?

STERIS plc's acquisition of Xodus Medical was reported on October 12, 2026. STERIS STE has agreed to acquire Xodus Medical for $2.1 billion. The deal is expected to close by December 31, 2026, subject to regulatory approvals. Xodus Medical will generate approximately $245 million in revenue by 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Xodus Medical do?

Xodus Medical is a leader in innovative surgical solutions focused on improving patient safety, enhancing clinical outcomes, and supporting perioperative teams. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.